List of articles with "Eli Lilly"

Eli Lilly's 150th Anniversary

Eli Lilly's 150th Anniversary

United States New York Eli Lilly scientific innovation NYSE LLY
Eli Lilly's $4.5 Billion Push

Eli Lilly's $4.5 Billion Push

United States Eli Lilly Indiana Genetic Medicine Lebanon, Indiana
Lilly's Omvoh Breakthrough

Lilly's Omvoh Breakthrough

United States Indianapolis Ulcerative Colitis Eli Lilly Omvoh
Eli Lilly Q2 Dividend

Eli Lilly Q2 Dividend

United States Dividend Indianapolis pharmaceuticals Eli Lilly
Lilly Q1 2026 Results

Lilly Q1 2026 Results

United States Indianapolis Eli Lilly Mounjaro Foundayo
Eli Lilly Japan and Obesity Society

Eli Lilly Japan and Obesity Society

Japan Eli Lilly Health Promotion Kobe Obesity Society
FuturHealth's New Oral Treatment

FuturHealth's New Oral Treatment

USA San Diego Eli Lilly FuturHealth Foundayo
Lilly Acquires Ajax

Lilly Acquires Ajax

USA Indianapolis Eli Lilly JAK2 Inhibitor Ajax Therapeutics
Lilly Acquires Kelonia

Lilly Acquires Kelonia

United States Indianapolis CAR-T therapy Eli Lilly Kelonia Therapeutics
Foundayo Trial Results

Foundayo Trial Results

United States Indianapolis Eli Lilly diabetes treatment Foundayo
Foundayo™ Now Available

Foundayo™ Now Available

USA Salt Lake City Eli Lilly Shed Foundayo™
Jaypirca's Impact on CLL

Jaypirca's Impact on CLL

USA Indianapolis Eli Lilly CLL Jaypirca
Foundayo Weight Loss Pill

Foundayo Weight Loss Pill

USA Indianapolis Eli Lilly Orforglipron Foundayo
Weight Loss Market Trends

Weight Loss Market Trends

None Novo Nordisk Eli Lilly Global Obesity Market
Foundayo™ Launch

Foundayo™ Launch

United States New York Eli Lilly Ro Foundayo™
Foundayo™ Launch

Foundayo™ Launch

United States Indianapolis Eli Lilly Orforglipron Foundayo™
Obesity Awareness Film

Obesity Awareness Film

Japan obesity Eli Lilly Tanabe Pharma Kobe, Osaka
Foundayo™ Approved

Foundayo™ Approved

USA Indianapolis Eli Lilly Orforglipron Foundayo™
Centessa Investigation

Centessa Investigation

United States New York Eli Lilly Juan Monteverde Centessa Pharmaceuticals
FDA Approves Foundayo™

FDA Approves Foundayo™

United States Indianapolis Eli Lilly Orforglipron Foundayo
Lilly Acquires Centessa

Lilly Acquires Centessa

USA Indianapolis Eli Lilly Centessa Pharmaceuticals OX2R agonists
EBGLYSS for Eczema

EBGLYSS for Eczema

United States Indianapolis Atopic Dermatitis Eli Lilly EBGLYSS
Retatrutide Phase 3 Trial

Retatrutide Phase 3 Trial

United States Indianapolis Eli Lilly Type 2 Diabetes retatrutide
EBGLYSS for Atopic Dermatitis

EBGLYSS for Atopic Dermatitis

USA Indianapolis Atopic Dermatitis Eli Lilly EBGLYSS
Kroger Introduces Zepbound® KwikPen

Kroger Introduces Zepbound® KwikPen

USA Kroger Cincinnati Zepbound Eli Lilly
WHO and Lilly Collaboration

WHO and Lilly Collaboration

Switzerland Geneva Eli Lilly Obesity Care WHO Foundation
WHO and Lilly Team Up

WHO and Lilly Team Up

Switzerland Geneva Eli Lilly Obesity Treatment WHO Foundation
WHO and Lilly Team Up

WHO and Lilly Team Up

Switzerland Geneva Eli Lilly Obesity Care WHO Foundation
Lilly Enhances Obesity Care Access

Lilly Enhances Obesity Care Access

United States Indianapolis Zepbound Eli Lilly Obesity Care
Zepbound KwikPen Update

Zepbound KwikPen Update

USA Indianapolis Zepbound Eli Lilly KwikPen
Omvoh's Long-term Efficacy

Omvoh's Long-term Efficacy

United States Indianapolis Crohn's Disease Eli Lilly Omvoh
Lilly Acquires Orna

Lilly Acquires Orna

United States Indianapolis CAR-T therapy Eli Lilly Orna Therapeutics
Lilly Q4 2025 Earnings

Lilly Q4 2025 Earnings

United States Indianapolis Zepbound Eli Lilly Mounjaro
Insulin Resistance Market Growth

Insulin Resistance Market Growth

USA Las Vegas Eli Lilly Insulin Resistance OrsoBio
Lilly's New Facility

Lilly's New Facility

United States Manufacturing Pennsylvania Eli Lilly Lehigh Valley
Ventyx Sale Inquiry

Ventyx Sale Inquiry

USA New Orleans Kahn Swick Eli Lilly Ventyx Biosciences
Leadership in Healthcare

Leadership in Healthcare

United States Eli Lilly COVID-19 Montgomery David Thrasher
Sofetabart Mipitecan FDA Approval

Sofetabart Mipitecan FDA Approval

United States Indianapolis Eli Lilly Ovarian Cancer Sofetabart Mipitecan
Strive vs Pharma Giants

Strive vs Pharma Giants

USA Novo Nordisk Gilbert Eli Lilly Strive Compounding Pharmacy
HealthDyne Obesity Solutions

HealthDyne Obesity Solutions

USA Lakeland Eli Lilly Obesity Treatment HealthDyne
Ventyx Sale Investigation

Ventyx Sale Investigation

USA New Orleans Kahn Swick Eli Lilly Ventyx Biosciences
Investigation of Ventyx

Investigation of Ventyx

United States Milwaukee Eli Lilly Ademi LLP Ventyx Biosciences
Lilly Acquires Ventyx

Lilly Acquires Ventyx

USA Indianapolis Eli Lilly NLRP3 Inhibitors Ventyx Biosciences
ABL Bio's $40M Deal

ABL Bio's $40M Deal

South Korea Seoul Eli Lilly ABL Bio Grabody
FlyteHealth's Obesity Care

FlyteHealth's Obesity Care

USA Eli Lilly New Canaan FlyteHealth obesity management
Orforglipron Weight Loss

Orforglipron Weight Loss

United States Indianapolis Eli Lilly Obesity Treatment Orforglipron
MEDI&GENE and Lilly's Obesity Drug

MEDI&GENE and Lilly's Obesity Drug

South Korea Seoul Eli Lilly Obesity Therapeutics MEDI&GENE
Lilly at JPM Healthcare

Lilly at JPM Healthcare

USA Indianapolis Healthcare Conference J.P. Morgan Eli Lilly
Inluriyo Efficacy Update

Inluriyo Efficacy Update

USA Indianapolis Eli Lilly Verzenio Inluriyo
Lilly's $6 Billion Facility

Lilly's $6 Billion Facility

United States Huntsville Eli Lilly API Manufacturing

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.